Reaction
Retinal Depigmentation reporting signals
As of the last recalculation, Retinal Depigmentation appears in 302 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 186.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 58 | 186.1 | 186.5 |
| Melphalan Hydrochloride | 40 | 126.6 | 126.8 |
| Melphalan | 33 | 112.1 | 112.3 |
| Aflibercept | 25 | 60.1 | 60.2 |
| Entecavir | 6 | 36.1 | 36.1 |
| Vigabatrin | 4 | 19.2 | 19.2 |